MedPath

A prospective study to compare the efficacy of empirical Vs tailored therapy in refractory GERD

Not Applicable
Not yet recruiting
Conditions
Health Condition 1: K210- Gastro-esophageal reflux disease with esophagitis
Registration Number
CTRI/2023/02/049407
Lead Sponsor
not applicable
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1) refractory to PPI therapy for GERD

2) Given written consent and willing to follow up

Exclusion Criteria

1) on drugs which may effect motility of esophagus

2) known cases of carcinoma esophagus

3) known cases of achalasia cardia

4) pregnant women

5) previous history of esophageal surgeries

6) previous history of esophageal endoscopic interventions

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the efficacy of treatment strategies in refractory GERDTimepoint: after two months of therapy
Secondary Outcome Measures
NameTimeMethod
to describe the spectrum of findings of OGD, HRM, pH monitoring in refractory GERDTimepoint: 2 years
© Copyright 2025. All Rights Reserved by MedPath